Envista Holdings Co. (NYSE:NVST) Shares Sold by Leeward Investments LLC MA

Leeward Investments LLC MA cut its holdings in shares of Envista Holdings Co. (NYSE:NVST) by 5.7% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 549,840 shares of the company’s stock after selling 33,235 shares during the period. Leeward Investments LLC MA owned 0.32% of Envista worth $10,606,000 at the end of the most recent quarter.

A number of other large investors have also made changes to their positions in the business. GAMMA Investing LLC increased its position in shares of Envista by 30.5% during the fourth quarter. GAMMA Investing LLC now owns 2,304 shares of the company’s stock worth $44,000 after purchasing an additional 538 shares in the last quarter. Allspring Global Investments Holdings LLC increased its position in shares of Envista by 50.8% during the third quarter. Allspring Global Investments Holdings LLC now owns 2,161 shares of the company’s stock worth $43,000 after purchasing an additional 728 shares in the last quarter. Blue Trust Inc. increased its position in shares of Envista by 69.7% during the third quarter. Blue Trust Inc. now owns 1,957 shares of the company’s stock worth $39,000 after purchasing an additional 804 shares in the last quarter. Huntington National Bank increased its position in shares of Envista by 97.8% during the third quarter. Huntington National Bank now owns 1,919 shares of the company’s stock worth $38,000 after purchasing an additional 949 shares in the last quarter. Finally, Hudson Edge Investment Partners Inc. increased its position in shares of Envista by 4.8% during the fourth quarter. Hudson Edge Investment Partners Inc. now owns 24,931 shares of the company’s stock worth $481,000 after purchasing an additional 1,150 shares in the last quarter.

Analysts Set New Price Targets

NVST has been the topic of several research reports. Mizuho initiated coverage on Envista in a research report on Wednesday, December 4th. They issued an “underperform” rating and a $20.00 target price on the stock. Robert W. Baird upped their target price on Envista from $17.00 to $22.00 and gave the company a “neutral” rating in a research report on Thursday, October 31st. Jefferies Financial Group upped their target price on Envista from $20.00 to $22.00 and gave the company a “hold” rating in a research report on Thursday, January 23rd. Morgan Stanley upped their target price on Envista from $19.00 to $20.00 and gave the company an “equal weight” rating in a research report on Thursday, February 6th. Finally, Wells Fargo & Company upped their target price on Envista from $20.00 to $21.00 and gave the company an “equal weight” rating in a research report on Thursday, February 6th. Two investment analysts have rated the stock with a sell rating, nine have assigned a hold rating and three have assigned a buy rating to the company’s stock. Based on data from MarketBeat, Envista currently has an average rating of “Hold” and an average target price of $20.21.

Envista Trading Down 2.5 %

NVST stock opened at $20.91 on Friday. The company’s 50-day simple moving average is $20.11 and its 200-day simple moving average is $19.52. The company has a quick ratio of 1.76, a current ratio of 2.04 and a debt-to-equity ratio of 0.44. Envista Holdings Co. has a 52-week low of $15.15 and a 52-week high of $23.06. The firm has a market cap of $3.60 billion, a P/E ratio of -3.22, a PEG ratio of 1.27 and a beta of 1.34.

Envista (NYSE:NVST) last posted its earnings results on Wednesday, February 5th. The company reported $0.24 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.23 by $0.01. Envista had a negative net margin of 44.56% and a positive return on equity of 3.86%. As a group, equities analysts forecast that Envista Holdings Co. will post 1 EPS for the current fiscal year.

About Envista

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.